CytomX Therapeutics, Inc. (CTMX) announced a profit for its first quarter that increased from last year and beat the Street estimates.
The company's earnings came in at $23.53 million, or $0.27 per share. This compares with $13.79 million, or $0.17 per share, last year.
Analysts on average had expected the company to earn $0.13 per share. Analysts' estimates typically exclude special items.
The company's revenue for the period rose 22.3% to $50.92 million from $41.63 million last year.
CytomX Therapeutics, Inc. earnings at a glance (GAAP) :
-Earnings: $23.53 Mln. vs. $13.79 Mln. last year.
-EPS: $0.27 vs. $0.17 last year.
-Revenue: $50.92 Mln vs. $41.63 Mln last year.
For comments and feedback: editorial@rttnews.com